Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer.
New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer
Your email address will not be published. Required fields are marked *
Comment
Name *
Email *
Website
Leave a Reply